Supply Chain

While Mylan agreed to settle its Medicaid rebate case with the federal government last week for $465 million, the drugmaker is not required to classify EpiPens as a branded drug under Medicaid's rebate program until April 2017, reports CNBC.

The Wall Street Journal released an online poll Tuesday asking readers how confident they are about their companies' supply chains.

Samsung permanently stopped production on its Galaxy Note 7 smartphone Tuesday after issuing a recall upon reports of the device overheating and catching on fire. The recall, made last month, places a spotlight on supply-chain regulation, leaving the industry to…

Protein Sciences earned Food and Drug Administration approval for its quadrivalent formulation of the Flublok influenza vaccine, reports Monthly Prescribing Reference.

The Food and Drug Administration approved the use of the blood thinner drug Xarelto to treat patients with atrial fibrillation, or irregular heartbeat, reports Reuters.

Between 2013 and 2015, inpatient hospital drug costs jumped an average of 38.7 percent per admission, making it difficult for many hospitals to manage their budgets, according to a recent analysis from the independent research organization NORC at the University…

The Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Health System recently held the 4th annual Pediatric Surgical Innovation Symposium.

Inpatient hospital drug costs increased by an average of 38.7 percent per admission between 2013 and 2015, according to a recent analysis from the independent research organization NORC at the University of Chicago.

Genentech, a member of Basel, Switzerland-based Roche Group, earned priority review status for its drug Lucentis.

Saint Paul, Minn.-based Saint Jude Medical issued a warning this week about issues with premature battery depletion in some of its implanted heart devices. So far, the issue has been linked to two deaths, reports Reuters.